37 CD8+ T lymphocyte infiltration in breast cancer was correlated with good clinical prognosis,38,39 especially in TNBC.40 Together, our results indicated that CXCL13 expression in the 4T1 tumor microenvironment triggered both innate and adaptive antitumor immune responses. The gene discussed is CD8A; the disease is neoplasm.